Mary M Stevenson Selected Research

TiterMax

4/2006

Reduced protective efficacy of a blood-stage malaria vaccine by concurrent nematode infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary M Stevenson Research Topics

Disease

24	Infections 01/2019 - 02/2002
19	Malaria 11/2019 - 02/2002
6	Anemia 01/2017 - 02/2004
3	Inflammation (Inflammations) 01/2019 - 11/2010
3	Nematode Infections 10/2017 - 06/2005
3	Reticulocytosis 01/2014 - 02/2004
2	Cerebral Malaria 01/2016 - 11/2010
2	Parasitemia 02/2009 - 03/2007
2	Coinfection 04/2006 - 06/2005
1	Persistent Infection 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Iron Overload 01/2017
1	Ulcerative Colitis 01/2017
1	Splenomegaly 01/2017
1	Cystinosis 01/2016
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2014
1	Neuroinflammatory Diseases 01/2013
1	Sepsis (Septicemia) 11/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2007
1	Pyruvate Kinase Deficiency of Red Cells 07/2007
1	Hemolytic Anemia 07/2007
1	Body Weight (Weight, Body) 11/2006
1	Helminthiasis (Helminthiases) 06/2005
1	beta-Thalassemia (Cooley's Anemia) 12/2003
1	Sickle Cell Anemia (Hemoglobin S Disease) 12/2003
1	Necrosis 11/2002
1	Pseudomonas Infections 11/2002

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 02/2009 - 04/2002
5	AntigensIBA 01/2022 - 09/2003
5	Erythropoietin FDA Link 01/2014 - 02/2004
5	Interleukin-12 (IL 12)IBA 08/2007 - 02/2002
3	VaccinesIBA 01/2022 - 09/2003
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 05/2006
3	Pyruvate KinaseIBA 01/2017 - 12/2003
3	Messenger RNA (mRNA)IBA 10/2016 - 04/2002
3	EnzymesIBA 01/2016 - 05/2004
3	pantetheinase (pantetheine hydrolase)IBA 01/2016 - 03/2007
3	Proteins (Proteins, Gene)FDA Link 12/2014 - 01/2007
3	Interferon-gamma (Interferon, gamma)IBA 02/2009 - 09/2003
3	Interleukin-4 (Interleukin 4)IBA 02/2009 - 09/2003
3	Immunoglobulins (Immunoglobulin)IBA 05/2006 - 09/2003
3	Interleukin-10 (Interleukin 10)IBA 06/2005 - 11/2002
2	hemozoinIBA 11/2019 - 01/2014
2	LigandsIBA 01/2019 - 12/2014
2	Pharmaceutical PreparationsIBA 01/2017 - 06/2005
2	Cysteamine (Mercaptamine)FDA Link 01/2016 - 08/2010
2	Interleukin-15 (Interleukin 15)IBA 02/2009 - 05/2005
2	InterferonsIBA 02/2009 - 11/2002
2	CPG-oligonucleotideIBA 11/2006 - 09/2003
2	Antimalarials (Antimalarial Agents)IBA 04/2006 - 06/2005
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2006 - 06/2005
2	InterleukinsIBA 11/2002 - 11/2002
1	Hemoglobins (Hemoglobin)IBA 11/2019
1	Heme (Haem)IBA 11/2019
1	Chemokine ReceptorsIBA 01/2019
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 10/2017
1	ChitosanIBA 01/2017
1	IronIBA 01/2017
1	HydrogelsIBA 01/2017
1	catechol (pyrocatechol)IBA 01/2017
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 10/2016
1	Sulfhydryl Compounds (Thiols)IBA 01/2016
1	artemisinin (artemisinine)IBA 01/2016
1	artemotil (arteether)IBA 01/2016
1	Drug CombinationsIBA 01/2016
1	ArtemisininsIBA 01/2016
1	ArtesunateIBA 01/2016
1	Artemether FDA Link 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2014
1	ChromatinIBA 01/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	Interleukin-2 (IL2)IBA 04/2011
1	CaspasesIBA 11/2010
1	InflammasomesIBA 11/2010
1	Caspase 12IBA 11/2010
1	NF-kappa B (NF-kB)IBA 11/2010
1	Monoclonal AntibodiesIBA 02/2009
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 02/2009
1	Protein Isoforms (Isoforms)IBA 08/2007
1	Interleukin-12 Subunit p40IBA 08/2007
1	CystamineIBA 03/2007
1	ThiamphenicolIBA 11/2006
1	TiterMaxIBA 04/2006
1	Malaria VaccinesIBA 04/2006
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 01/2006
1	Coloring Agents (Dyes)IBA 01/2006
1	AnthelminticsIBA 06/2005
1	AntibodiesIBA 05/2005
1	Transferrin Receptors (Transferrin Receptor)IBA 05/2004
1	ImmunosorbentsIBA 05/2004
1	Neutralizing AntibodiesIBA 02/2004
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 12/2003
1	Aluminum Hydroxide (Algeldrate)FDA Link 09/2003
1	aluminum sulfate (alum)IBA 09/2003
1	OligodeoxyribonucleotidesIBA 09/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2002
1	Mannose ReceptorIBA 11/2002

Therapy/Procedure

2	Therapeutics 01/2016 - 12/2014
1	Immunomodulation 04/2016